Cargando…
Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge
Triple-Negative Breast Cancer (TNBC), represents a subtype of breast cancer in which the estrogens receptor (ER) negative, the progesterone receptor (PR) negative and the human epidermal growth factor receptor 2 (HER2) negative, are not expressed. Thusly, TNBC does not respond to hormonal therapies...
Autores principales: | Bimonte, Sabrina, Cascella, Marco, Barbieri, Antonio, Arra, Claudio, Cuomo, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954554/ https://www.ncbi.nlm.nih.gov/pubmed/31938038 http://dx.doi.org/10.1186/s13027-020-0270-5 |
Ejemplares similares
-
Dissecting the mechanisms and molecules underlying the potential carcinogenicity of red and processed meat in colorectal cancer (CRC): an overview on the current state of knowledge
por: Cascella, Marco, et al.
Publicado: (2018) -
An Overview on the Potential Roles of EGCG in the Treatment of COVID-19 Infection
por: Bimonte, Sabrina, et al.
Publicado: (2021) -
The Potential Roles of Epigallocatechin-3-Gallate in the Treatment of Ovarian Cancer: Current State of Knowledge
por: Bimonte, Sabrina, et al.
Publicado: (2020) -
The roles of epigallocatechin-3-gallate in the treatment of neuropathic pain: an update on preclinical in vivo studies and future perspectives
por: Bimonte, Sabrina, et al.
Publicado: (2017) -
Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression
por: Bimonte, Sabrina, et al.
Publicado: (2015)